View Older Stories View More Recent Stories

Jun 10, 2022 11:03AM Vertex Pharma (VRTX) to Present Data Demonstrating Significant Benefits of Long-Term and Early Treatment With CFTR Modulators at ECFS
Jun 10, 2022 11:00AM Vertex to Present Data Demonstrating Significant Benefits of Long-Term and Early Treatment With CFTR Modulators at the European Cystic Fibrosis Conference
Jun 4, 2022 08:05AM Gilead drug modestly delays breast cancer progression in late-stage trial
Jun 1, 2022 09:00AM Chiesi USA Announces First Analysis from the CAMEO Registry Assessing KENGREAL® (cangrelor) Use and Transition to Oral P2Y12 Inhibitors in Routine Clinical Practice
May 25, 2022 10:33AM Study from The Advertising Coalition Finds Advertising Drives $7.1 Trillion in US Sales
May 25, 2022 09:15AM RedHill Presents New Talicia® Data Analyses at DDW 2022
May 23, 2022 11:30AM Cytokinetics Announces Data From REDWOOD-HCM OLE and GALACTIC-HF Presented as Late Breaking Science Presentations at the European Society of Cardiology Heart Failure 2022 Congress
May 17, 2022 11:52AM End Drug Shortages Alliance Releases Market Assessment for Drugs Impacted by Manufacturing Plant Closure
May 11, 2022 08:51AM Blow to Roche's cancer immunotherapy prospects as 2nd trial fails
May 11, 2022 01:10AM Genentech Reports Interim Results for Phase III SKYSCRAPER-01 Study in PD-L1-High Metastatic Non-Small Cell Lung Cancer
May 11, 2022 01:00AM [Ad hoc announcement pursuant to Art. 53 LR] Roche reports interim results for phase III SKYSCRAPER-01 study in PD-L1-high metastatic non-small cell lung cancer
Apr 26, 2022 07:00AM Zambon to present data on lung transplantation trends and survival rates in Europe at ISHLT 2022
Apr 20, 2022 06:17AM New meta-analysis with Diamyd® published in scientific journal
Apr 19, 2022 08:30AM Fortress Information Security Receives $125 Million Strategic Investment from Goldman Sachs Asset Management
Apr 15, 2022 08:31AM TG Therapeutics (TGTX) Voluntarily Withdraws BLA/sNDA for U2 to Treat Patients with CLL and SLL
Apr 15, 2022 08:30AM TG Therapeutics Announces Voluntary Withdrawal of the BLA/sNDA for U2 to Treat Patients with CLL and SLL
Apr 11, 2022 10:05AM Gail Mahady Receives ABC Fredi Kronenberg Excellence in Research and Education in Botanicals for Women’s Health Award
Apr 11, 2022 10:05AM Gail Mahady Receives ABC Fredi Kronenberg Excellence in Research and Education in Botanicals for Women’s Health Award
Apr 7, 2022 02:00AM Emergex Signs Agreement with ATCC to Advance Studies of its Yellow Fever Booster Vaccine Candidate
Apr 3, 2022 12:00PM Esperion Announces Two NEXLETOL® (bempedoic acid) Data Presentations at the American College of Cardiology’s 71st Annual Scientific Session & Expo
Apr 3, 2022 12:00PM Esperion Announces Two NEXLETOL® (bempedoic acid) Data Presentations at the American College of Cardiology’s 71st Annual Scientific Session & Expo
Mar 23, 2022 06:00AM Two Years Into the Pandemic, Media Use Has Increased 17% Among Tweens and Teens
Mar 21, 2022 10:00AM 3billion to reveal its diagnostic performance at ACMG annual meeting 2022
Mar 17, 2022 08:34AM PureCycle Technologies (PCT) Appoints Steven F. Bouck and Allen Jacoby to its Board
Mar 17, 2022 08:30AM PureCycle Adds Top Industry Leaders to Board of Directors
Mar 14, 2022 07:00AM Bristol-Myers Squibb (BMY), Nektar (NKTR) Announce Phase 3 PIVOT IO-001 Trial Evaluating Bempegaldesleukin (BEMPEG) in Combination with Opdivo Did Not Meet Primary Endpoint
Mar 14, 2022 06:59AM Bristol Myers Squibb and Nektar Announce Update on Phase 3 PIVOT IO-001 Trial Evaluating Bempegaldesleukin (BEMPEG) in Combination with Opdivo (nivolumab) in Previously Untreated Unresectable or Metas
Feb 28, 2022 04:05PM Castle Biosciences Reports Fourth Quarter and Full-Year 2021 Results
Feb 28, 2022 08:45AM KnowBe4 Research: Half of Employees Use Unauthorized File Services to Complete Work
Feb 28, 2022 08:45AM KnowBe4 Research: Half of Employees Use Unauthorized File Services to Complete Work
Feb 24, 2022 08:00AM New MAVENCLAD® Data at ACTRIMS Forum 2022 Show Favorable Efficacy Outcomes Versus Other Oral DMTs and Lower Occurrence of Further Relapses or Disability Progression
Feb 10, 2022 05:00AM Insellerate Receives Growth Investment Led by Argentum
Feb 7, 2022 11:51AM World’s glaciers contain less ice than thought - report
Feb 7, 2022 10:15AM RedHill Biopharma (RDHL) Oral Opaganib Reduces Mortality by 70% Given on Top of Remdesivir and Corticosteroids in Severe COVID-19
Feb 7, 2022 10:15AM RedHill Biopharma's Oral Opaganib Reduces Mortality by 70% Given on Top of Remdesivir and Corticosteroids in Severe COVID-19
Feb 3, 2022 07:00AM Castle Biosciences Collaborates with the National Cancer Institute to Link DecisionDx®-Melanoma Testing Data with SEER Registries’ Cutaneous Melanoma Cases
Jan 13, 2022 04:37PM EDF updates its nuclear output estimate in France for 2022
Dec 16, 2021 09:00AM Kargo Announces First of Its Kind Partnership with NewsGuard and Industry-Leading Results with Oracle Moat, Validating Supply Quality 
Dec 2, 2021 03:00AM BeiGene to Present New Clinical Data on Tislelizumab at ESMO IO Congress 2021
Dec 1, 2021 05:02PM PhaseBio Pharmaceuticals Inc. (PHAS) Reports Publication of Interim Results from Pivotal REVERSE-IT Phase 3 Trial of Bentracimab
Dec 1, 2021 05:01PM PhaseBio Announces Publication of Interim Results from Pivotal REVERSE-IT Phase 3 Trial of Bentracimab in NEJM Evidence
Nov 18, 2021 07:00AM SaaS Ecommerce Provider Miva Announces Strategic Growth Investment from Equality Asset Management
Nov 5, 2021 08:12AM Shockwave Medical (SWAV) Unveils First One-Year Results of Coronary Intravascular Lithotripsy
Nov 5, 2021 08:00AM Shockwave Medical Unveils First One-Year Results of Coronary Intravascular Lithotripsy
Nov 5, 2021 08:00AM Shockwave Medical Unveils First One-Year Results of Coronary Intravascular Lithotripsy
Nov 4, 2021 10:00AM New data at ASH spotlight Novartis recently approved Scemblix®, next-generation CAR-T platform and expanding hematology portfolio
Oct 20, 2021 04:15PM NANOBIOTIX Provides Third Quarter Operational and Financial Update
Oct 13, 2021 07:01AM Lender Price Receives Strategic Investment Led by Argentum to Support Rapid Growth
Sep 19, 2021 07:30AM Byondis ESMO Late-Breaking Presentation Confirms ADC [Vic-] Trastuzumab Duocarmazine (SYD985) Superior to Physician's Choice in Pre-treated Locally Advanced or Metastatic HER2-Positive Breast Cancer
Aug 31, 2021 10:59AM New White Paper From Westfleet Advisors Finds that Despite Aggressive Disclosure Efforts, U.S. Courts Continue to Protect Confidentiality of Litigation Funding
View More Recent Stories View Older Stories